Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells

Medulloblastoma (MB) is the most common malignant brain tumor of childhood. Current therapies are toxic and not always curative that necessitates development of targeted immunotherapy. However, little is known about immunobiology of this tumor. In this study, we show that MB cells in 9 of 20 primary...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Liu, Daofeng, Song, Liping, Brawley, Vita S., Robison, Nathan, Wei, Jie, Gao, Xiuhua, Tian, Gengwen, Margol, Ashley, Ahmed, Nabil M., Asgharzadeh, Shahab, Metelitsa, Leonid S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3809126/
https://ncbi.nlm.nih.gov/pubmed/23891738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2013.06.005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia